Evaluation of Dilution Susceptibility Testing Methods for Aztreonam in Combination with Avibactam against Enterobacterales
ABSTRACT As multidrug and pan-resistance among Enterobacterales continue to increase, there is an urgent need for more therapeutic options to treat these infections. New β-lactam and β-lactam inhibitor (BLI) combinations have a broad spectrum of activity, but those currently approved do not provide...
Main Authors: | C. J. Kelley, A. Kennedy-Mendez, O. N. Walser, M. T. Thwaites, F. F. Arhin, C. M. Pillar, D. A. Hufnagel |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2022-12-01
|
Series: | Microbiology Spectrum |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/spectrum.03601-22 |
Similar Items
-
In vitro activity of aztreonam/avibactam against isolates of Enterobacterales collected globally from ATLAS in 2019
by: Gian Maria Rossolini, et al.
Published: (2022-09-01) -
Case report: Continuous infusions of ceftazidime-avibactam and aztreonam in combination through elastomeric infusors for 12 weeks for the treatment of bone and joint infections due to metallo-β-lactamase producing Enterobacterales
by: Yanis Merad, et al.
Published: (2023-08-01) -
Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Enterobacterales Analyzed by ICU and Non-ICU Wards, Infection Sources, and Geographic Regions: ATLAS Program 2016–2020
by: Denis Piérard, et al.
Published: (2023-11-01) -
Treatment in Infections by Enterobacterales Producing Extended Spectrum Betalactamase. Systematic Review
by: Carli Samira Aziz Delgado, et al.
Published: (2021-10-01) -
In vitro activity of aztreonam-avibactam and comparators against Metallo-β-Lactamase-producing Enterobacterales from ATLAS Global Surveillance Program, 2016–2020
by: Gian Maria Rossolini, et al.
Published: (2024-03-01)